Resonance Health Ltd

Company Profile

• Business description

  Resonance Health Ltd is a healthcare company specializing in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its product includes FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver, Cardiac T2, and HepaFat-Scan. It also has several AI-assisted SaMDs including FerriSmart, HepaFat-AI, and LiverSmart. The company's business segments are; Services which derives key revenue, Research and development, Corporate, Clinical Research Organization (CRO), and TrialsWest. Geographically, it generates maximum revenue from the Asia Pacific and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.

• Contact

  141-143 Burswood Road
  Level 1
  Burswood
  PerthWA6100
  AUS

  T: +61 892865300

  https://www.resonancehealth.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Health Information Services

  Fiscal Year End

  30 June 2026

  Employees

  18